Analystreport

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) had its "buy" rating re-affirmed by analysts at Credit Suisse Group. They now have a $9.00 price target on the stock.

FOAMIX PHARMACEUTICALS LTD  (FOMX) 
Last foamix pharmaceuticals ltd earnings: 11/11 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.foamix.co.il